GapMind for catabolism of small carbon sources

 

Alignments for a candidate for etfA in Azospirillum brasilense Sp245

Align butanoyl-CoA dehydrogenase (NAD+, ferredoxin) (subunit 1/3) (EC 1.3.1.109) (characterized)
to candidate AZOBR_RS05475 AZOBR_RS05475 protein fixB

Query= BRENDA::Q18AQ5
         (336 letters)



>FitnessBrowser__azobra:AZOBR_RS05475
          Length = 359

 Score =  263 bits (672), Expect = 5e-75
 Identities = 136/321 (42%), Positives = 204/321 (63%), Gaps = 4/321 (1%)

Query: 4   VLVVIEQRENVIQTVSLELLGKATEIAKDYDTKVSALLLGS---KVEGLIDTLAHYGADE 60
           + V++EQ    + +VS EL+G+A ++A     +V A++LG+   ++  +      YGAD 
Sbjct: 24  IWVIVEQERGSVHSVSWELVGEARKLADKLGVEVGAVVLGADSPELNAICGDAFTYGADV 83

Query: 61  VIVVDDEALAVYTTEPYTKAAYEAIKAADPIVVLFGATSIGRDLAPRVSARIHTGLTADC 120
           V  V D  LA Y T+PYT+   + +    P +VL GAT++GRDLA  ++  + TGLTADC
Sbjct: 84  VYKVTDPVLADYRTDPYTRVMTDVVNTYKPEIVLLGATTLGRDLAGAIATTLATGLTADC 143

Query: 121 TGLAVAEDTKLLLMTRPAFGGNIMATIVCKDFRPQMSTVRPGVMKKNEPDETKEAVINRF 180
           T L +  D + L  TRP FGG ++ TI    +RPQM+TVRP VM   + D+++   +   
Sbjct: 144 TELDIYMDNRSLAATRPTFGGTLLCTIQTLAYRPQMATVRPRVMSMPDRDDSRTGRVVEV 203

Query: 181 KVEFNDADKLVQVVQVIKEAKK-QVKIEDAKILVSAGRGMGGKENLDILYELAEIIGGEV 239
                + D + +V+  I + ++ + ++  A I+V+AG+G+G  ENL ++++LA+++GGEV
Sbjct: 204 FPNLRETDVITKVLSFIADREQTEAQLAFADIIVAAGKGLGKPENLKLVFDLAKVLGGEV 263

Query: 240 SGSRATIDAGWLDKARQVGQTGKTVRPDLYIACGISGAIQHIAGMEDAEFIVAINKNPEA 299
             +R  + AGW    RQVGQTGKTVRP LYIA GISGAIQH  GME ++ I+AIN +P A
Sbjct: 264 GVTRPLVQAGWTGFDRQVGQTGKTVRPKLYIAAGISGAIQHRVGMEKSDLILAINTDPNA 323

Query: 300 PIFKYADVGIVGDVHKVLPEL 320
           PIF +A +G+VGD   +LP L
Sbjct: 324 PIFDFAHLGLVGDALTILPAL 344


Lambda     K      H
   0.316    0.135    0.371 

Gapped
Lambda     K      H
   0.267   0.0410    0.140 


Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 1
Number of Hits to DB: 342
Number of extensions: 10
Number of successful extensions: 3
Number of sequences better than 1.0e-02: 1
Number of HSP's gapped: 1
Number of HSP's successfully gapped: 1
Length of query: 336
Length of database: 359
Length adjustment: 29
Effective length of query: 307
Effective length of database: 330
Effective search space:   101310
Effective search space used:   101310
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.6 bits)
S2: 49 (23.5 bits)

This GapMind analysis is from Sep 17 2021. The underlying query database was built on Sep 17 2021.

Links

Downloads

Related tools

About GapMind

Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.

A candidate for a step is "high confidence" if either:

where "other" refers to the best ublast hit to a sequence that is not annotated as performing this step (and is not "ignored").

Otherwise, a candidate is "medium confidence" if either:

Other blast hits with at least 50% coverage are "low confidence."

Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:

GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).

For more information, see:

If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know

by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory